Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1952Archives of Internal Medicine

L-Arterenol (Levophed®) in the Treatment of Shock Due to Acute Myocardial Infarction

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does L-arterenol improve outcomes in patients with shock due to acute myocardial infarction?

Population

Patients with shock due to acute myocardial infarction

Design

Other

Authors

AMAlbert J. MillerNorthwestern University

Discussion

Loading...

Member takes

Implication

Supports norepinephrine in post-MI cardiogenic shock; extends early RCT rationale for vasopressor therapy.

Structured PICO

Does L-arterenol improve outcomes in patients with shock due to acute myocardial infarction?

P
Population
Patients with shock due to acute myocardial infarction
I
Intervention
L-arterenol (Levophed / norepinephrine)

This text discusses the early rationale for using L-arterenol (norepinephrine) to treat severe cardiogenic shock complicating acute myocardial infarction.

Cite This Study

Albert J. Miller (1952) studied this question.

synapsesocial.com/papers/6a1551aa5347fbb1739f95f5https://doi.org/10.1001/archinte.1952.00240040070009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PROGNOSTIC VALUE OF VARIOUS CLINICAL AND ELECTROCARDIOGRAPHIC FEATURES OF ACUTE MYOCARDIAL INFARCTION1941 · 87 citations
  2. 2TREATMENT OF SHOCK IN RECENT MYOCARDIAL INFARCTION BY INTRA-ARTERIAL TRANSFUSION1951 · 30 citations
  3. 3RECENT MYOCARDIAL INFARCTION1947 · 161 citations